Anlon Healthcare
03 Sep '25MAINBOARD
Min. Investment
₹14,104
Issue size
₹121.03 Cr
GMP
Locked
Overall subscription: 1.69x
Expert verdict
IPO dates
26 Aug
Opening
29 Aug
Closing
01 Sep
Allotment
03 Sep
Listing
*Refunds will be initiated on 02 Sep '25
IPO quota
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 164 | ₹14,924 |
| HNI (Min) | 14 | 2296 | ₹2,08,936 |
Subscription (as on 26 August 2025, 06:46 PM)
Overall1.69x
Qualified institutional buyers
Non-Institutional Buyers
Retail Investors
Employee
About company
Founded: 2013|MD: Mr. Punitkumar R. Rasadia
- Anlon Healthcare is a chemical manufacturing company specialising in the production of high-purity pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Pharmaceutical intermediates are raw materials or key starting materials for APIs. In contrast, APIs are used in finished dosage formulas such as tablets, capsules, ointments, and syrups, as well as in nutraceuticals, personal care, and animal health products.
- The company’s portfolio includes pharmaceutical intermediates, APIs, nutraceutical APIs, and ingredients for personal care and veterinary applications. Its APIs are manufactured in compliance with Indian and international pharmacopoeia standards, including the Indian Pharmacopoeia (IP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), Japanese Pharmacopoeia (JP), and United States Pharmacopoeia (USP).
- The company has also started custom manufacturing of complex and novel chemical compounds, adapting processes to meet specific client requirements, including higher purity levels where needed. It is also involved in API development and the preparation and filing of Drug Master Files (DMFs) in both domestic and international markets.
Issue Details & Objective
Lot size
164 Shares
Price band
₹86 to 91
Face value
₹10 per share
Financials
IPO reservation
Anchor investor - 75.00%
HNI - 15.00%
Retail - 10.00%
Download DRHP (IPO Doc)FAQs
Should I apply for the Anlon Healthcare IPO?
Our SEBI-registered investment advisors give out verdicts for each IPO. You can refer to their expert verdict at the top of this page. Please note that these verdicts are for informational purposes only and should not be construed as investment advice. Markets are subject to risk, and investors should exercise their own discretion and diligence.
What is the issue size of Anlon Healthcare IPO?
The issue size of Anlon Healthcare IPO is ₹121.03 Cr
What are the open and close dates for Anlon Healthcare IPO?
The Anlon Healthcare IPO will be open for applications from 26 Aug '25 to 29 Aug '25
What is the lot size and minimum order quantity of Anlon Healthcare IPO?
The lot size of Anlon Healthcare IPO is 164 Shares and its minimum investment amount is ₹14,104.
What is the GMP value of Anlon Healthcare IPO?
Grey market premium (GMP) is a premium amount at which grey market IPO shares are traded before they get listed in the stock exchange. The GMP for Anlon Healthcare IPO is 5.49
